University of Minnesota. Driven to Discover.
The alliance aims to boost transparency, communication, quality, redundancy, and production.
"When prescription drugs are not affordable or accessible for any reason, consumers can experience lost work days, disease...
"Just as chemicals can build up in the air, viruses can as well."
Test to treat will allow patients who test positive to be treated with free antiviral pills on the spot.
COVID has compounded how the lack of country-of-origin data can affect drug safety, affordability, availability, and national security.
Unlike previous outbreaks, the fungus appeared to have pan-resistance prior to patient treatment.
Experts say drug compounding is a stopgap measure, not a solution.
"The CDC got the science right, but the policy and communication was really wrong."
While states are becoming optimistic, experts continue to advocate for aerosol-related mitigations.
A study assessing use of a medical mask under a cloth mask for COVID-19 has some scientists concerned.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2022 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.